Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors

NCT04830501 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: TT-00434

Sponsor

TransThera Sciences (Nanjing), Inc.